2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$9.38-$0.04 (-0.37%)
Price as of Oct 22, 2026 4:25 PM EDT- $230.6MMarket Cap
- -44.74%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$9.38-$0.04 (-0.37%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.41 | ||
Change | -$0.29 (-2.99%) | ||
Open | $9.65 | ||
High | $10.12 | ||
Low | $9.29 | ||
Previous Close | $9.70 | ||
Volume | 118,319 | ||
30-Day Average Volume | 168,644 | ||
1-Week Change | 17.77% | ||
1-Month Change | -13.91% | ||
1-Year Change | -44.74% | ||
3-Year Change | -69.65% | ||
5-Year Change | -96.61% | ||
Fundamentals | |||
Shares Outstanding | 24.5M | ||
Total Assets | $311.2M | ||
Market Cap | $230.6M | ||
Enterprise Value | $157.6M | ||
Period: QTR TTM FY | |||
Revenue | $4,000.00 | ||
Net Income | -$44.8M | ||
Free Cash Flow | -$34.2M | ||
EBIT | -$44.8M | ||
EBITDA | -$42.5M | ||
Net Working Capital | $173.7M | ||
EPS | -$1.92 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 39,402 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue